Form EFFECT Biodexa Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 30, 2026 5:00 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- From $5M in grateful patient giving to faster AI adoption: Kindsight honors client success at the 2026 Kindness Awards
- Colorado Personal Injury Firm Turns $50,000 Offer Into $500,000+ Settlement Using EvenUp's AI Platform
- NSSF Welcomes Federal Court Decision Temporarily Blocking Conn.'s Unconstitutional Gun Ban
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share